131 filings
Page 5 of 7
424B3
IMTX
Immatics N.V
26 May 21
Prospectus supplement
7:34am
6-K
IMTX
Immatics N.V
26 May 21
Immatics Announces Changes to its Board of Directors
7:30am
424B3
IMTX
Immatics N.V
18 May 21
Prospectus supplement
11:33am
6-K
IMTX
Immatics N.V
18 May 21
Current report (foreign)
8:09am
424B3
IMTX
Immatics N.V
11 May 21
Prospectus supplement
7:19am
6-K
IMTX
Immatics N.V
11 May 21
Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA402 Targeting PRAME
7:13am
EFFECT
IMTX
Immatics N.V
5 Apr 21
Notice of effectiveness
12:15am
6-K
IMTX
Immatics N.V
1 Apr 21
Current report (foreign)
7:31am
20-F
2020 FY
IMTX
Immatics N.V
Annual report (foreign)
30 Mar 21
7:51am
6-K
IMTX
Immatics N.V
30 Mar 21
Current report (foreign)
7:18am
POS AM
IMTX
Immatics N.V
30 Mar 21
Prospectus update (post-effective amendment)
12:00am
6-K
IMTX
Immatics N.V
19 Mar 21
Current report (foreign)
7:30am
424B3
IMTX
Immatics N.V
17 Mar 21
Prospectus supplement
7:33am
6-K
IMTX
Immatics N.V
17 Mar 21
Immatics Presents Data Update on Dose Escalation from Ongoing ACTengine® Cell Therapy Programs
7:31am
SC 13G
Arya Sciences Holdings
16 Feb 21
Immatics / ARYA SCIENCES ownership change
12:00am
SC 13G
dievini Hopp BioTech holding GmbH & Co KG
12 Feb 21
Immatics / dievini Hopp BioTech holding GmbH & Co KG ownership change
1:02pm
6-K
IMTX
Immatics N.V
6 Jan 21
Current report (foreign)
12:00am
424B3
IMTX
Immatics N.V
2 Dec 20
Prospectus supplement
8:46am
6-K
IMTX
Immatics N.V
2 Dec 20
Current report (foreign)
8:08am
424B3
IMTX
Immatics N.V
9 Oct 20
Prospectus supplement
5:10pm